Michael Aristides
Michael Aristides publishes mostly in Economics and Econometrics, Pulmonary and Respiratory Medicine and Oncology, on topics such as Health Systems, Economic Evaluations, Quality of Life, Lung Cancer Treatments and Mutations and Economic and Financial Impacts of Cancer.
- World rank
- #3,747,168 of 7,710,434 ranked researchers
- Rank in United States
- #1,035,294 of 1,627,098
- Works
- 56
- Citations
- 720
- Citations per work
- 12.9
What does Michael Aristides research?
Michael Aristides's work is mostly in Medicine (47%), Economics, Econometrics and Finance (20%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2646.9%
- Medicine2646.9%
- Everything else1832.7%
- Social Sciences1120.4%
- 1Economics and Econometrics20% of their works
- 2Pulmonary and Respiratory Medicine19% of their works
- 3Oncology12% of their works
- 4Endocrinology, Diabetes and Metabolism7% of their works
- 5Radiology, Nuclear Medicine and Imaging6% of their works
- 6Surgery3% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Lung Cancer Treatments and Mutations
- Economic and Financial Impacts of Cancer
- Colorectal Cancer Treatments and Studies
- Lung Cancer Diagnosis and Treatment
- Radiopharmaceutical Chemistry and Applications
- Cancer Genomics and Diagnostics
- Pancreatic and Hepatic Oncology Research
Which keywords describe Michael Aristides's research?
The keywords of their largest research topics: Targeted Therapy, Chemotherapy, Cost-effectiveness Analysis, Quality of Life, ALK Inhibitors, EGFR Mutations, Cost of Care and Financial Toxicity.
- Surgical Complications
- Mutational Signatures
- Radiopharmaceuticals
- Lung Cancer
- KRAS Mutations
- Financial Toxicity
- EGFR Mutations
- Quality of Life
- Chemotherapy
- Targeted Therapy
- Cost-effectiveness Analysis
- ALK Inhibitors
- Cost of Care
- Cetuximab
- CT Screening
- PET Imaging
- Cancer Genomics
- Pancreatic Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Targeted Therapy213 topics
- Chemotherapy153 topics
- Cost-effectiveness Analysis151 topic
- Quality of Life151 topic
- ALK Inhibitors121 topic
- EGFR Mutations121 topic
- Cost of Care91 topic
- Financial Toxicity91 topic
- Cetuximab61 topic
- KRAS Mutations61 topic
- CT Screening51 topic
- Lung Cancer51 topic
- PET Imaging51 topic
- Radiopharmaceuticals51 topic
- Cancer Genomics41 topic
- Mutational Signatures41 topic
- Pancreatic Cancer41 topic
- Surgical Complications41 topic
Where does Michael Aristides work?
Michael Aristides's main affiliation in the publication record is Eli Lilly (United States), United States.
How many publications and citations does Michael Aristides have?
OpenAlex counts 56 works and 720 citations for Michael Aristides, an h-index of 10, ranking #3,747,168 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael Aristides. Posts are plain text and can be reported.